NUCLEIX

nucleix-logo

Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.

#SimilarOrganizations #People #Financial #Website #More

NUCLEIX

Social Links:

Industry:
Biotechnology Health Care Information Technology Manufacturing Medical Device Personal Health

Founded:
2008-01-01

Address:
Rehovot, HaMerkaz, Israel

Country:
Israel

Website Url:
http://www.nucleix.com

Total Employee:
11+

Status:
Active

Contact:
+97289161616

Email Addresses:
[email protected]

Total Funding:
82.99 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache


Similar Organizations

angeion-corporation-logo

Angeion Corporation

Angeion Corp develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems.

crossway-logo

CROSSWAY

CROSSWAY develops and manufactures physical fitness diagnostic systems and measuring devices.

ewave-logo

eWAVE

eWAVE develops, manufactures, and markets optical transport systems.

norman-biological-technology-logo

Norman Biological Technology

Norman Biological Technology is a manufacturer of automated chemiluminescence system.


Current Advisors List

dan-j-gelvan_image

Dan J. Gelvan Member of Board of Directors @ Nucleix
Board_member

Current Employees Featured

adam-wasserstrom_image

Adam Wasserstrom
Adam Wasserstrom Co-founder, VP Software & Analytics @ Nucleix
Co-founder, VP Software & Analytics
2008-07-01

danny-frumkin_image

Danny Frumkin
Danny Frumkin VP Research & Co-founder @ Nucleix
VP Research & Co-founder

chris-hibberd_image

Chris Hibberd
Chris Hibberd Chief Executive Officer @ Nucleix
Chief Executive Officer
2020-01-01

w-todd-myers_image

W. Todd Myers
W. Todd Myers Chief Financial Officer @ Nucleix
Chief Financial Officer
2019-08-01

chris-hibberd_image

Chris Hibberd
Chris Hibberd Executive Chairman @ Nucleix
Executive Chairman
2019-08-01

Founder


adam-wasserstrom_image

Adam Wasserstrom

danny-frumkin_image

Danny Frumkin

elon-ganor_image

Elon Ganor

Investors List

zohar-zisapel_image

Zohar Zisapel

Zohar Zisapel investment in Venture Round - Nucleix

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Venture Round - Nucleix

sands-capital-ventures_image

Sands Capital Ventures

Sands Capital Ventures investment in Venture Round - Nucleix

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Nucleix

oci-bio-investments_image

OCI Bio Investments

OCI Bio Investments investment in Venture Round - Nucleix

blackrock_image

BlackRock

BlackRock investment in Venture Round - Nucleix

dsc-investment_image

DSC Investment

DSC Investment investment in Venture Round - Nucleix

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Venture Round - Nucleix

orbimed-advisors_image

OrbiMed

OrbiMed investment in Venture Round - Nucleix

milfam_image

MILFAM

MILFAM investment in Venture Round - Nucleix

Official Site Inspections

http://www.nucleix.com Semrush global rank: 9.84 M Semrush visits lastest month: 95

  • Host name: 104.26.15.33
  • IP address: 104.26.15.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Nucleix"

Nucleix โ€“ Company

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based โ€ฆSee details»

Nucleix Ltd. - LinkedIn

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based ...See details»

Nucleix - Crunchbase Company Profile & Funding

Nucleix develops, manufactures, and markets non-invasive molecular cancer โ€ฆSee details»

Nucleix Company Profile - Office Locations, Competitors ... - Craft

Nucleix has 5 employees across 2 locations and $60.97 m in total funding,. See insights on Nucleix including office locations, competitors, revenue, financials, executives, subsidiaries โ€ฆSee details»

Nucleix - Org Chart, Teams, Culture & Jobs | The Org

View Nucleix's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Nucleix - Israeli Startup | Startup Nation Finder

Mar 16, 2022 Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. โ€ฆSee details»

Nucleix 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Nucleix. Use the PitchBook Platform to explore the full profile.See details»

Nucleix โ€“ About Us

About Us Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest โ€ฆSee details»

Nucleix Ltd. - LinkedIn

Nucleix Ltd. | 6,987 followers on LinkedIn. Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the โ€ฆSee details»

Nucleix Ltd. - Drug pipelines, Patents, Clinical trials - Synapse

Jun 23, 2025 Explore Nucleix Ltd. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, 21 news, and 5 literature.See details»

Nucleix Org Chart + Executive Team - The Official Board

The org chart of Nucleix contains its 21 main executives like Chris Hibberd and Todd Myers.See details»

Nucleix

Nucleixโ€™s Bladder EpiCheck® Receives FDA 510 (k) Clearance for Monitoring of Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence READ MORESee details»

Nucleix | StartupHub.ai

Nucleix is a healthcare startup founded in 2008 that specializes in liquid biopsy for early-stage and recurring cancer detection. They use methylation-based identification and their non-invasive โ€ฆSee details»

Nucleix - The Org

Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products โ€ฆSee details»

Nucleix Ltd. - VentureRadar

"Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging โ€ฆSee details»

Nucleix โ€“ Careers

US OFFICE Phone +1-858-283-3398 10675 Sorrento Valley Road, Ste 250, San Diego, CA 92121See details»

Nucleix โ€“ Technology

Nucleix was built around DNA methylation expertise, and we were the first to develop a methylation-based tissue identification assay 1,2. The EpiCheck assay determines the โ€ฆSee details»

Nucleix - Profiles & Contacts - Crunchbase

Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.See details»

Nucleix โ€“ News&Events

May 6, 2024 Nucleix to Present Data Showcasing Performance and Clinical Utility of Bladder EpiCheck® Monitoring in Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence at AUA โ€ฆSee details»

Nucleix โ€“ Videos

The role of biomarkers in the diagnostic process of bladder carcinoma. Watch the presentation of Dr. Félix Guerrero Ramos (Madrid, Spain) October 14th, 2021 The 1st virtual International โ€ฆSee details»

linkstock.net © 2022. All rights reserved